Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2025)

Twist Bioscience (TWST) has disclosed Income from Continuing Operations for 6 consecutive years, with 46313000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Income from Continuing Operations rose 9.41% to 46313000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was 204666000.0, a 6.06% increase, with the full-year FY2025 number at 77651000.0, up 62.8% from a year prior.
  • Income from Continuing Operations was 46313000.0 for Q3 2023 at Twist Bioscience, up from 57373000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 24317000.0 in Q3 2020 to a low of 60668000.0 in Q1 2022.
  • A 5-year average of 42110842.11 and a median of 41271000.0 in 2021 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 145.76% in 2019, then surged 40.87% in 2020.
  • Twist Bioscience's Income from Continuing Operations stood at 55638000.0 in 2019, then soared by 40.87% to 32900000.0 in 2020, then tumbled by 38.49% to 45563000.0 in 2021, then increased by 8.21% to 41824000.0 in 2022, then decreased by 10.73% to 46313000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Income from Continuing Operations are 46313000.0 (Q3 2023), 57373000.0 (Q2 2023), and 59156000.0 (Q1 2023).